儿童脊髓室管膜瘤:法国回顾性研究
该法国多中心回顾性研究纳入2000至2010年治疗的28例18岁以下脊髓室管膜瘤患儿,中位手术年龄13.67岁,初期全切除22例、次全切除6例,5年无进展生存率为51%,总生存率100%,单因素分析仅全切除对无进展生存有显著影响。
要点
- 儿童脊髓室管膜瘤少见,本研究28例中全切除22例、次全切除6例。
- 5年无进展生存率51%(95%CI 26.3%-71.2%),总生存率100%。
- 单因素分析仅全切除对无进展生存有显著影响(P=0.0013)。
核心结论
- 数据提示初期辅助放疗可能改善全切除后的无进展生存,但不能预防次全切除患者的复发。
- 需要进一步研究为次全切除组定义更特异的治疗。
研究设计与样本
- 法国回顾性多中心研究,收集2000至2010年治疗的28例年龄<18岁脊髓室管膜瘤患者数据。
- 分析流行病学、肿瘤及治疗相关数据,评估无进展生存的预后因素。
主要发现
- 共28例患者(22例男性,6例女性),手术时中位年龄13.67岁(范围0.7-17.6岁)。
- 初期全切除22例,次全切除6例;组织学为黏液乳头型室管膜瘤15例、II级11例、III级2例。
- 6例患者接受初期辅助放疗;中位随访40个月(范围2.3-127.5个月)。
- 5年无进展生存率51%(95%CI 26.3%-71.2%),总生存率100%。
- 单因素分析仅全切除对无进展生存有显著影响(P=0.0013);亚组分析显示全切除患者接受放疗有获益,但放疗未能预防初期次全切除组复发。
关键数值与推荐
- 5年无进展生存率51%(95%CI 26.3%-71.2%),总生存率100%。
- 单因素分析中全切除对无进展生存影响显著(P=0.0013)。
临床怎么用
- 儿童脊髓室管膜瘤治疗数据提示初期全切除与无进展生存相关。
- 全切除后辅助放疗可能改善无进展生存,但次全切除后放疗未能预防复发。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ependymoma is the most frequent spinal tumor in adults but it is rather uncommon in children. The aim of the present study was to retrospectively summarize the clinical and therapeutic experience in the treatment of pediatric spinal ependymomas in France. METHODS: In the present retrospective multicenter study, data from patients aged <18 years who had been treated from 2000 to 2010 for spinal ependymomas were collected. Epidemiologic and tumor- and treatment-related data were analyzed. The prognostic factors for progression-free survival (PFS) were assessed. RESULTS: We identified 28 patients (22 males, 6 females). Their median age at surgery was 13.67 years (range, 0.7-17.6). Initial gross total resection (GTR) was achieved in 22 children and subtotal resection (STR) in 6. Histologically, 15 tumors were myxopapillary ependymomas and 11 were grade II and 2 grade III ependymomas. Adjuvant initial radiotherapy (RT) was performed in 6 patients. The median follow-up period was of 40 months (range, 2.3-127.5). The 5-year PFS rate was 51% (95% confidence interval, 26.3%-71.2%), and the overall survival rate was 100%. On univariate analysis, only GTR had a significant influence on PFS (P = 0.0013). A subgroup analysis showed a benefit of RT delivered to patients with GTR; however, RT failed to prevent relapse in the group with initial STR. CONCLUSIONS: Our data suggest that initial adjuvant RT might improve PFS after GTR but will not prevent relapse in patients with STR. Further studies are needed to define more specific treatments for the latter group.
引用
- Szathmari A, Zerah M, Vinchon M, et al. Ependymoma of the Spinal Cord in Children: A Retrospective French Study. World Neurosurg. 2019. PMID: 30877001. doi:10.1016/j.wneu.2019.03.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。